Development and comparison of three 89Zr-labeled anti-CLDN18.2 antibodies to noninvasively evaluate CLDN18.2 expression in gastric cancer: a preclinical study
Guilan Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Huo(Chinese Academy of Medical Sciences & Peking Union Medical College), Chao Fu(Wuhan No.1 Hospital), Peipei Zhou(St. Jude Children's Research Hospital), Yuan Wang(Sichuan University), Yu Liu(Sichuan University), Fang Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Zheng Zhang(Central South University), Wenwen Duan(Shanghai Mental Health Center), Shikun Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenjia Zhu(Peking Union Medical College Hospital)
Cited by 39
Related Papers
Caffeine
|Unknown|2016|300
Caffeine: Toward Uniformed Representation and Acceleration for Deep Convolutional Neural Networks
|IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems|2018|268
Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas
|Nature Communications|2023|224
mTOR signaling at the crossroads of environmental signals and T‐cell fate decisions
|Immunological Reviews|2020|188
Covalent targeted radioligands potentiate radionuclide therapy
|Nature|2024|165